Clinical Trial Update: Safety and Efficacy Study of Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nab-paclitaxel plus gemcitabine in Chinese patients with metastatic pancreatic cancer has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Neoplasms

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Celgene | Conditions: Pancreatic Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2016-11-22